Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. | MicrobiomeTrials← Back to trialsNCT06992609
Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-09-15Est. Completion: 2029-06-30
Enrollment target: 70 participants Locations- Research Site, A Coruña, Spain
- Research Site, Badajoz, Spain
- Research Site, Barakaldo, Spain
- Research Site, Barcelona, Spain
- Research Site, Barcelona, Spain
- Research Site, Barcelona, Spain
- Research Site, Jerez de la Frontera, Spain
- Research Site, Madrid, Spain
- Research Site, Madrid, Spain
- Research Site, Málaga, Spain
- Research Site, Oviedo, Spain
- Research Site, Santander, Spain
- Research Site, Seville, Spain
- Research Site, Valencia, Spain
- Research Site, Zaragoza, Spain
Other microbiome trials you might be interested in
Advanced/Metastatic Non-Small Cell Lung Cancer
This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metas…
Goodyear, United StatesEst. completion Jun 24, 2030
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatm…
Anchorage, United StatesEst. completion Dec 31, 2026
Small Cell Lung Carcinoma
This exploratory trial aims to determine if it is safe to use radiotherapy and lurbinectedin to treat SCLC with Single-l…
Beijing, ChinaEst. completion Dec 2026